The global pharmaceutical industry is currently estimated to be worth $1 trillion. Contributors chart the rise of scientific marketing within the industry from 1920-1980. This is the first comprehensive study into pharmaceutical marketing, demonstrating that many new techniques were actually developed in Europe before being exported to America.

The global pharmaceutical industry is currently estimated to be worth $1 trillion. Contributors chart the rise of scientific marketing within the industry from 1920-1980. This is the first comprehensive study into pharmaceutical marketing, demonstrating that many new techniques were actually developed in Europe before being exported to America.

Recent scholarship has revealed that pioneering Victorian scientists endeavored through voluminous writing to raise public interest in science and its implications. But it has generally been assumed that once science became a profession around the turn of the century, this new generation of scientists turned its collective back on public outreach. Science for All debunks this apocryphal notion. Peter J. Bowler surveys the books, serial works, magazines, and newspapers published between 1900 and the outbreak of World War II to show that practicing scientists were very active in writing about their work for a general readership. Science for All argues that the social environment of early twentieth-century Britain created a substantial market for science books and magazines aimed at those who had benefited from better secondary education but could not access higher learning. Scientists found it easy and profitable to write for this audience, Bowler reveals, and because their work was seen as educational, they faced no hostility from their peers. But when admission to colleges and universities became more accessible in the 1960s, this market diminished and professional scientists began to lose interest in writing at the nonspecialist level. Eagerly anticipated by scholars of scientific engagement throughout the ages, Science for All sheds light on our own era and the continuing tension between science and public understanding.

There has been much discussion about the origin of marketing and marketing thought, and whether it was truly American in origin. Nevertheless, it is true that US marketing management thought was very influential throughout the world in the latter half of the twentieth century, becoming dominant after the Second World War. In order to recognize why and how this kind of thought developed in the USA, it is necessary to explore the historical contexts in which the marketing management thought was produced and developed at this time, as well as the contents of the thought. This work argues that while doubts about the US origin of marketing are acceptable, marketing management thought, which especially appeals to mass producers such as the USA, developed according to their particular needs. This book looks at the relationship between theories of marketing and the historical context in which they were developed, rescuing them from later generalizations that failed to take into account contemporary social and economic factors.

The heroic story of the invention of antidepressants is a key part of the psychopharmaceutical turn. On Trial revolves around one of its pioneers, psychiatrist Roland Kuhn, who practiced in Münsterlingen, a state-run psychiatric hospital in Switzerland. Kuhn became famous for the ‘discovery’ of the first antidepressant, Tofranil, and more recently notorious for his numerous trials on often unsuspecting patients. Largely based on the extensive and previously inaccessible sources of Kuhn’s private archive, the book delves into the early days of industry-sponsored clinical research in psychiatry. It examines how the clinic, patients, doctors, nursing staff, corporations, and authorities interacted in the trials. Conducted from the 1940s to 1980s, the Münsterlingen drug trials are historicised and situated in the period’s evolving landscape of experimentation.

Harp uses the familiar figure of Bibendum and the promotional campaigns designed around him to analyze the cultural assumptions of "belle-epoque" France, including representations of gender, race and class. He also considers Michelin's efforts to promote automobile tourism in France and Europe through its famous "Red Guide" (first introduced in 1900), noting that, in the aftermath of World War I, the company sold tour guides to the battlefields of the Western Front and favourably positioned France's participation in the war as purely defensive and unavoidable. Throughout this period, the company successfully identified the name of Michelin with many aspects of French society, from cuisine and local culture to nationalism and colonialism.

This book examines the wide range of scientific and social arenas in which the concept of inheritance gained relevance in the late nineteenth and early twentieth centuries. Although genetics emerged as a scientific discipline during this period, the idea of inheritance also played a role in a variety of medical, agricultural, industrial, and political contexts. The book, which follows an earlier collection, Heredity Produced (covering the period 1500 to 1870), addresses heredity in national debates over identity, kinship, and reproduction; biopolitical conceptions of heredity, degeneration, and gender; agro-industrial contexts for newly emerging genetic rationality; heredity and medical research; and the genealogical constructs and experimental systems of genetics that turned heredity into a representable and manipulable object. Taken together, the essays in Heredity Explored show that a history of heredity includes much more than the history of genetics, and that knowledge of heredity was always more than the knowledge formulated as Mendelism. It was the broader public discourse of heredity in all its contexts that made modern genetics possible.